Bader Gnehm & Partner has appointed Alain P. Röthlisberger (pictured) as of counsel. He focuses on contract law, commercial and company law, mergers and acquisitions, joint ventures, restructuring company successions as well as private
Tags :Bader Gnehm & Partner
Numab Therapeutics, a clinical stage biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation, successfully closes CHF 100 million (approximately USD 110 million) in Series C financing Round. The financing was co-led by new investors
